The importance of the newly developed tomographic ultrasound robot.

Updated: Oct 13, 2021

On the 15th of September, 2021, Vexev announced their invention of the tomographic ultrasound robot (TUR, shown below). Vexev (a palindrome), is a Sydney-based medical device start-up company working to improve the efficiency and efficacy of 21st century medical devices. Historically, cardiovascular disease, and other vascular disorders, were diagnosed using 2D ultrasounds machines. These machines were not affordable, inconsistent, and produced only 2D images. Further, the sonographers who operated this machinery are in short supply and often suffer from repetitive strain injury (RSI) leading to decreased service in this career field.

The development of TUR technology is not only revolutionary to automating the vascular imaging process, but also providing more efficient and higher quality images that are comparable to their more costly counterparts: MRI and CT imaging. “The TUR will be tested in upcoming clinical trials at Sydney’s Eastern Suburbs Vascular Imaging, which is located at the Prince of Wales Hospital campus. The trials are supported by Australian vascular surgeons such as Dr Shannon Thomas, A/Prof Ramon Varcoe, Dr Andrew Lennox and Dr Tom Daly.”